| Charmaine K Shen, MD | |
|
2417 Central Ave, Alameda, CA 94501-4515 | |
| (510) 752-1000 | |
| Not Available |
| Full Name | Charmaine K Shen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 2417 Central Ave, Alameda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922016880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A107295 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Britain's Department of Health and Ranbaxy (UK) Ltd have jointly announced settlement of the claims brought against Ranbaxy for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs between 1996 and 2000.
A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
A unique health economics assessment of copper's role in preventing healthcare-associated infections is being presented this week at the WHO's International Conference on Prevention and Infection Control in Geneva, demonstrating rapid payback on the capital investment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a Phase IIb trial in adult lung transplant patients with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in 10% to 20% of infected patients.
› Verified 1 days ago
| Entity Name | John Muir Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841407665 PECOS PAC ID: 6608789813 Enrollment ID: O20031226000143 |
News Archive
Britain's Department of Health and Ranbaxy (UK) Ltd have jointly announced settlement of the claims brought against Ranbaxy for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs between 1996 and 2000.
A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
A unique health economics assessment of copper's role in preventing healthcare-associated infections is being presented this week at the WHO's International Conference on Prevention and Infection Control in Geneva, demonstrating rapid payback on the capital investment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a Phase IIb trial in adult lung transplant patients with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in 10% to 20% of infected patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charmaine K Shen, MD 115 Central Ave, Alameda, CA 94501-3244 Ph: (415) 595-9712 | Charmaine K Shen, MD 2417 Central Ave, Alameda, CA 94501-4515 Ph: (510) 752-1000 |
News Archive
Britain's Department of Health and Ranbaxy (UK) Ltd have jointly announced settlement of the claims brought against Ranbaxy for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs between 1996 and 2000.
A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
A unique health economics assessment of copper's role in preventing healthcare-associated infections is being presented this week at the WHO's International Conference on Prevention and Infection Control in Geneva, demonstrating rapid payback on the capital investment.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a Phase IIb trial in adult lung transplant patients with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. RSV infection in lung transplant patients represents an important unmet medical need; the condition is associated with significant morbidity, including the development of acute lung transplant rejection in 10% to 20% of infected patients.
› Verified 1 days ago
Dr. Lorraine Bonner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2070 Clinton Ave, Rm 2113, Alameda, CA 94501 Phone: 510-814-4397 Fax: 510-814-4391 | |
Dr. William S Lowery, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave, Alameda, CA 94501 Phone: 510-814-4089 Fax: 510-521-4187 | |
Dr. Anita C. Gaind, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2217 S Shore Ctr Ste 250, Alameda, CA 94501 Phone: 510-323-4410 Fax: 510-694-0776 | |
Dr. Alvaro Daniel Waissbluth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave Fl 3, Alameda, CA 94501 Phone: 510-522-6323 | |
Kinjal Patel, Internal Medicine Medicare: Medicare Enrolled Practice Location: 2217 S Shore Ctr # 250, Alameda, CA 94501 Phone: 510-323-4410 Fax: 510-694-0776 | |
David R. Craney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2417 Central Ave, Alameda, CA 94501 Phone: 510-749-5731 | |
Dr. Catherine K Pyun, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave, Alameda, CA 94501 Phone: 510-514-4397 Fax: 510-814-4391 |